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Purpose: To formulate carbomer gel to localize and target drug action in periodontal pockets.  
Methods: Diclofenac sodium (DS, anti-inflammatory) and metronidazole hydrochloride (MH, antibacterial) 
were loaded in gelatin microspheres using glutaraldehyde cross-linking. The microspheres were evaluated 
for drug loading, entrapment and encapsulation efficiency, particle size, drug release as well as by scanning 
electron microscopy (SEM) and differential scanning calorimetry (DSC). The microspheres were 
incorporated into carbomer gel and evaluated for drug release.  
Results: Loading, entrapment and encapsulation efficiencies of DS in the microsphere were 23.4, 93.6, and 
74.9 w/w%, respectively, while for MH the values were 21.5, 86.0 and 73.1 % w/w, respectively.  Mean 
particle size of unloaded microspheres, DS- and MH-loaded microspheres was 33.5, 67.8 and 51.4 µm, 
respectively. SEM showed spherical geometry of microspheres while DSC indicated the amorphous nature 
of t entrapped DS and MH. Sustained release of DS and MH over a 4-h period from the microspheres and 
gel was achieved.  
Conclusion: Carbomer gel loaded with microspheres of diclofenac and metronidazole is a potential 
localized delivery system for the treatment inflammation and infection in periodontal pockets.                                                                                         
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Periodontitis is an inflammatory disease 
caused by chronic bacterial infection of the 
gum and bone supporting the teeth [1,2]. 
Antimicrobial agents such as metronidazole, 
tetracycline and erythromycin are used to 
treat bacterial infections in periodontal 
diseases [3]. Non-steroidal anti-inflammatory 
drugs (NSAIDs) such as ibuprofen and 
diclofenac sodium are used to treat pain and 
inflammation. These drugs are administered 
locally as gel or given orally in the form of 
tablets.  Due to their short half life, these 
medications have to be taken frequently to 
maintain the desired therapeutic effect.  
 
In periodontal diseases, both drugs are used 
simultaneously to treat infection and 
inflammation. A single delivery system which 
can deliver both drugs is expected to be more 
convenient, beneficial and improve patient 
compliance. Hence in the present 
investigation, we have attempted to develop 
a gel formulation loaded with diclofenac 
sodium and metronidazole. Since the 
preparation has the same base at the time of 
administration, gel containing diclofenac 
sodium and metronidazole can be simply 
mixed and applied to the periodontal cavity 
with a special dispenser [4] used by the 
periodontist to deliver medication or gel 
formulation into periodontal pockets.   
 
Though microspheres loaded with 
antimicrobials have been reported and are 
currently available in the market [5], none 
includes microspheres loaded with both an 
anti-inflammatory and antimicrobial drugs. 
Sustained release formulations will be 
beneficial to patients with gastric ulceration or 
sensitivity to the drug, as the drug effect 
would be localized. Administration of the 
conventional drug delivery systems of 
metronidazole leads to side effects such as 
nausea and vomiting [6].  
 
Carbomer (carboxy vinyl polymer) is a very 
high molecular weight polymer of acrylic acid 
with cross linkages of allyl sucrose [7]. Due to 
the high proportion of the carboxy groups 
present, carbomer solution is known to be 
acidic. It is also of low viscosity but when 
neutralized with triethanolamine, it is 
converted to highly viscous gels. The 
adhesive prosperities of carbomer are 
exploited to develop bioadhesive gels and 
drug delivery systems for controlled and 
localized drug delivery [8-10]. .  
 
To obtain a sustained and targeted delivery, 
drugs can encapsulated in gelatin 
microspheres, which are then formulated as a 
gel using carbomer. To overcome problems 
associated with the conventional system, we 
aimed to develop a bioadhesive gel 
formulation which can sustain and localize 







Gelatin (type B, 300 bloom strength) was 
purchased from Sigma Chemicals, USA. 
Carbopol 934 and triethanolamine GR (99 % 
purity) were purchased from Loba Chemie, 
India. Metronidazole hydrochloride and 
diclofenac sodium were gifts from Arvind 
Remedies, Thiruvellore, Chennai, India. 
Glutaraldehyde and isopropyl alcohol were 
obtained from S.D. Fine Chemicals Ltd., 
Mumbai, India. Span 80, Tween 80, acetone 
and toluene were purchased from Indian 
Research Products, Chennai, India. 
 
Preparation of gelatin microspheres  
 
Three grams of gelatin were accurately 
weighed and mixed in 10 ml of distilled water; 
preheated to 60 ºC, followed by the addition 
of Tween 80 (0.1 %w/v). To this, 1 g of 
diclofenac sodium was added and thoroughly 
mixed to obtain a homogeneous solution. The 
mixture was maintained at 50 C, and then 
added drop wise into 100 ml of sesame oil 
containing Span 80 (0.1 %w/v) preheated to 
60 C while stirring at 1000 rpm with a 3-
blade stirrer (Remi, India) in order to form a 
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w/o emulsion. Toluene (0.5 ml) saturated with 
glutaraldehyde was added drop-wise to the 
emulsion and stirring and stirred for 1 h at 
room temperature to stabilize the 
microspheres. The mixture was then left to 
cool at between 5 – 10 °C for 30 min to 
enhance settling of the microspheres. The 
microspheres were collected by filtration 
using Whatman filter paper (no. 41) and 
washed with 3 x 10 ml of chloroform followed 
by 2 x 10 ml of 5 %w/v sodium 
metabisulphite. Finally, the microspheres 
were washed with 10 ml of acetone, dried at 
room temperature and transferred to glass 
vials that were stored in desiccators until 
used. Similarly, microspheres loaded with 
metronidazole and unloaded microspheres 
were formulated and stored in desiccators. 
 
Preparation of gel 
 
Preparation of the carbomer gel was based 
on a previously reported composition and 
method [7]. Accurately weighed diclofenac 
sodium (100 mg) was added to 15 ml of 
water in a beaker and stirred well to dissolve 
the drug; 400 mg of carbopol was dissolved 
in this drug solution. Gelatin microspheres 
loaded with 100 mg of diclofenac sodium was 
added to the drug-carbopol solution and 
mixed well. Methyl hydroxybenzoate (0.15 
%w/w), propyl hydroxybenzoate (0.05 %w/w) 
and sodium metabisulphate (0.1 %w/w)) were 
then added to microsphere/drug/carbopol 
mixture, while stirring at 250 rpm, to obtain a 
homogenous mixture. Stirring was continued 
until a lump-free suspension was obtained. 
Thereafter, 0.33 ml of triethanolamine was 
added to produce a gel. This was followed by 
the addition of a sweetening agent (saccharin 
sodium, 0.1 %w/w) and more water to make 
up to 20 g of gel. Similarly, a gel containing 
metronidazole hydrochloride was prepared. 
The amount of metronidazole used was the 
same as that of diclofenac. 
 
Determination of drug content  
 
The amount of diclofenac sodium presents in 
the gelatin microspheres was determined by 
digestion with 1M sodium hydroxide [11].  
Briefly, 100 mg of microspheres was 
dispersed in 100 ml of 1M sodium hydroxide 
in a 100 ml standard flask. and kept overnight 
for 12 h. It was then filtered, diluted and 
diclofenac sodium content was determined 
spectrophotometrically (Shimadzu 1601) at 
276 nm. Sodium hydroxide (M) was used as 
blank. The amount of metronidazole present 
in gelatin microspheres was determined by 
digestion with hydrochloric acid [12]. Briefly, 
100 mg of microspheres was dispersed in 
100 ml of 1M hydrochloric acid in a 100 ml 
standard flask and kept overnight for 12 h. It 
was then filtered, diluted and metronidazole 
hydrochloride content was determined at 320 
nm. Hydrochloric acid (1M) was used as 
blank. .  
 
Determination of percentage of drug 
loading  
 
The percentage of diclofenac sodium and 
metronidazole hydrochloride loading in 





where, L is the loading (%) of microspheres, 
Qm is the quantity of diclofenac sodium and 
metronidazole hydrochloride present in Wm of 
microspheres and Wm is the weight of the 
microspheres in grams 
 
Determination of encapsulation efficiency  
 
The amount of diclofenac sodium and 
metronidazole hydrochloride encapsulated in 






where E is encapsulation efficiency (%), 
pQ is the quantity of drug encapsulated in the 
microspheres (g), tQ is the actual quantity of 
drug used for encapsulation (g), and 
pQ  is the product of drug content per gm of 
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Particle size analysis 
 
The microspheres were analyzed for size and 
size distribution by first dispersing them in 20 
% v/v isopropyl alcohol to avoid swelling, 
vortexing for 3 min and ultrasonicating for 30 
s before sampling. The particle size was 
measured by laser diffraction (Shimadzu Sald 
1100, Japan) and plotted for size distribution 
using the software supplied by the 
manufacturer. 
 
Scanning electron microscopy  
 
The sample the scanning electron 
microscopy (SEM) analysis was prepared by 
sprinkling the microspheres on one side of 
the double adhesive stub.  The stub was then 
coated with gold using Jeol JFC 1100 sputter 
coater.  The SEM analysis of the 
microspheres was carried out using Jeol JSM 
5300, Japan.  The microspheres were viewed 
at an accelerating voltage of 15-20 kV. 
 
Differential scanning calorimetry  
 
Differential scanning calorimetry (DSC) of 
diclofenac sodium, metronidazole hydro-
chloride and microspheres were performed 
using Perkin-Elmer DSC7 model.  The 
instrument was calibrated with indium.  All the 
samples (5 mg) were heated in sealed 
aluminum pans with perforated lids using dry 
nitrogen as the effluent gas. The analysis 
was performed in the temperature range of 
50 – 400 °C and at a rate of 20°C min-1. 
 
Evaluation of in vitro release by static 
method 
 
Microspheres, equivalent to 10 mg of 
diclofenac sodium, were accurately weighed 
and transferred to 250 ml conical flask 
containing 100 ml phosphate buffer (pH 7.2). 
The flask was kept in an incubator at 37 C, 1 
ml samples  withdrawn at regular intervals 
and, after suitable dilution, the amount of 
drug released was determined using a 
spectrophotometer at 276 nm. Following 
each sample withdrawal, 1 ml of phosphate 
buffer was added to the release medium to 
replenish it. Five minutes before each 
sampling, the flasks were gently shaken by 
manually whirling it clockwise (15 revolutions) 
to minimize any concentration gradient within 
the release medium. The microspheres were 
allowed to settle down and clear supernatant 
medium withdrawn for drug analysis. The 
sample was filtered and the microspheres 
collected were transferred to the dissolution 
flask. Similarly, the release of metronidazole 
hydrochloride from gelatin microspheres was 
determined spectrophotometrically at 320 nm 
(Shimadzu 1601).  
 
Evaluation of in vitro release by dynamic 
method 
 
Evaluation in vitro release studies of 
diclofenac sodium or metronidazole 
hydrochloride from the carbomer gel was 
carried out at 37 C using phosphate buffer 
(pH 7.2) as the release medium. A glass tube 
of 10 mm diameter and 100 mm height was 
taken. One end of the tube was closed using 
an egg membrane with the help of adhesive 
tape while the other end was kept open and 
used as drug reservoir compartment. Gel (1 
g) containing diclofenac sodium was 
accurately weighed and transferred to the 
glass tube in a vertical position through the 
open end. The gel was gently pushed down 
to the surface of the egg membrane with the 
help of a stainless steel spatula to ensure 
that all the gel was in contact with the 
membrane. Phosphate buffer (2 ml, pH 7.2) 
was added to the reservoir compartment to 
wet the gel. The glass tube was placed in a 
beaker containing 100 ml of phosphate buffer 
(pH 7.2) such that that the egg membrane is 
just immersed in the phosphate buffer which 
acted as the receiving compartment. The 
receiving compartment was magnetically 
stirred (100 rpm, Remi, India) at 37 C. 
Samples (1 ml) were withdrawn from the 
receiving compartment at regular intervals 
and the amount of diclofenac sodium 
released from the gel was determined using a 
spectrophotometer at 276 nm (Shimadzu 
1601). After each withdrawal of sample, an 
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equal quantity of phosphate buffer was added 
to the receiving compartment to replenish it. 
Similarly metronidazole hydrochloride release 
from the gel was determined 




Data obtained from in vitro release studies 
were fitted to various kinetic equations [11] to 
determine the mechanism of drug release 
from the microspheres.  The kinetic models 
used were zero order equation, first order 
equation and Higuchi release using the 
following plots: Qt vs t, log (Q0-Qt) vs t and Qt 
vs square root of t, respectively; where Qt is 
the amount of drug released at time t and Q0 
is the initial amount of drug present in the 
microspheres. T further, to ascertain the 
mechanism of drug release, the first 60 % of 
drug release was fitted to Korsmeyer-Peppas 
model (Eq 3). 
 
 Mt/M = ktn ……………………………….. (3) 
 
where Mt/M is the fraction of drug released 
at time, t, k is the rate constant and n is the 
release exponent.  The n value is used to 




Drug loading, entrapment and encapsulation 
efficiency data were analyzed by one sample 
T-test while drug release data were analyzed 
by two-way ANOVA. PASW 18 statistics 
software (IBM, USA) was used for statistical 
analysis and confidence level was set at p < 
0.05. 
 
RESULTS   
 
Drug loading, entrapment and encapsu-
lation efficiency  
 
The loading, entrapment and encapsulation 
efficiencies of the microspheres were 23.4, 
93.6 and 74.9 %, respectively, for diclofenac 
and 21.5, 86.0 and 73.1 %, respectively, for 
metronidazole. There was no significant 
difference (p > 0.05) between two drugs with 
regard to these parameters. 
 
Particle size of microspheres 
 
The size distribution profiles of the 
microspheres are shown in Figure 1. The 
particle size of unloaded microspheres 
ranged from 1 - 50 m compared with 10–
110 m for the drug-loaded microspheres. 
Mean diameter of unloaded, diclofenac 
sodium-loaded and metronidazole hydro-
chloride-loaded microspheres was 33.5, 67.8 
and 51.4 m, respectively.  
 
 
Figure 1: Particle size distributions of unloaded 
( ), diclofenac sodium-loaded ( ) and 
metronidazole hydrochloride-loaded ( ) gelatin 
microspheres. 
 
Scanning electron microscopy  
 
The microspheres exhibited good spherical 
geometry as evident by the SEM 
photomicrographs in Figure 2. However, 
diclofenac sodium microspheres were larger 
size and showed less aggregation than 
metronidazole microspheres.  
 
Differential scanning calorimetry  
 
The thermogram of unloaded microspheres 
showed no peaks while the thermogram of 
diclofenac sodium showed a sharp peak at its 
melting point (276 ºC). The physical mixture 
of unloaded microspheres and diclofenac 
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sodium showed a less prominent peak at 276 
ºC but the peak was absent in diclofenac 




Figure 2: SEM photographs of gelatin 
microspheres loaded with diclofenac sodium (left) 




Figure 3:  DSC thermograms of (A) diclofenac 
sodium, (B) physical mixture (1:1) of diclofenac 
sodium and unloaded gelatin microspheres and 
(C) gelatin microspheres loaded with diclofenac 
sodium 
 
Similarly, the thermogram of metronidazole 
hydrochloride showed a sharp peak at its 
melting point of 160 ºC while the physical 
mixture of unloaded microspheres and 
metronidazole hydrochloride showed a less 
prominent at 160 ºC and the peak was 





Figure 4:  DSC thermograms of (A) metronidazole 
hydrochloride, (B) physical mixture (1:1) of 
metronidazole hydrochloride and unloaded gelatin 
microspheres and (C) gelatin microspheres loaded 
with metronidazole hydrochloride 
 
In vitro drug release  
 
The cumulative release of diclofenac sodium 
and metronidazole from microspheres and 
gels are shown in Figure 5. Drug from the 
microspheres was released in a controlled 
manner for > 4 h. The release pattern was 
biphasic with an initial ‘burst’ release of 34 % 
of the loaded drug was in the first 10 min. 
Thereafter, release was slow but steady, and 
by the end of the 4th hour, 85 % of the loaded 
drug was released. 
 
Diclofenac release from the carbomer gel 
formulation is also shown in Figure 5. The 
release pattern was biphasic with an initial 
‘burst’ release that was enhanced by the 
loading dose of diclofenac sodium. By the 
end of the first 10 min, 45 to 48 % of the drug 
was released; subsequently, release was 
steady and by the end of the 4th h, 90 % of 
the drug was released. The data for the 
microsphere and gel containing metroni-
dazole are similar with slow drug release that 
reached a plateau in 3 – 4 h. There was 
significant difference (p < 0.05) between the 
release    rates   of   diclofenac    sodium and  
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              Time (min)        Time (min) 
 
Figure 5: In vitro release of (a) diclofenac sodium and (b) metronidazole from gelatin microspheres (□) and 
microspheres-loaded gel (◆); (n = 3). 
 
metronidazole from microspheres with the 
former greater. A similar difference between 
the two drugs was observed with regard to 




Drug release from the microspheres followed 
more closely the Higuchi model with a 
regression coefficient (r2) of 0.9793 
compared with first order ((r2 = 0.9522) and 
zero order models (r2 = 0.8289). Subjection of 
the release data to Korsmeyer- Peppas 
analysis yielded n value of 0.37 for diclofenac 
sodium and 0.38 for metronidazole hydro-




Sesame oil containing 0.1 %v/v Span 80 as 
dispersing medium produced drug-loaded 
gelatin microspheres with good loading and 
spherical geometry. The addition of 
surfactant contributed to the good spherical 
geometry and reduced aggregation of the 
microspheres. Diclofenac sodium was better 
encapsulated in gelatin microspheres than 
the metronidazole and this could be attributed 
to the high protein binding nature of 
diclofenac sodium [6]. 
 
The microspheres were incorporated in a 
conventional carbomer gel formulation [7]. 
Carbopol 934 is a commercial grade of 
carbomer. It is gelled by neutralization with 
triethanolamine. Methyl hydroxylbenzoate 
and propyl hydroxylbenzoate are used as 
antimicrobial preservative; while sodium 
metabisulphite is used as an anti-oxidant. 
The formulated carbomer gel was very clear, 
transparent and elegant. Incorporation of 
gelatin microspheres resulted in finely 
dispersed particles in the gel system. A 
loading dose of the free drug was 
incorporated in the carbomer gel to produce 
immediate effect while drug-loaded 
microspheres are added to provide sustaining 
dose. 
 
Volume-surface mean diameter microspheres 
is important in drug delivery because it is 
inversely related to the specific surface area 
[13] and hence the release rate. Larger the 
diameter, slower the drug release and vice 
versa.  
 
Drug-loaded microspheres were larger in size 
than the unloaded ones. Diclofenac sodium 
loaded microspheres were larger than 
metronidazole-loaded microspheres. Cross-
linking of gelatin with glutaraldehyde 
mormally would shrink the polymeric network 
[14], resulting in the reduction of particle size. 
The greater the degree of cross-linking the 
smaller the diameter microspheres. Perhaps, 
there was less cross-linking with diclofenac 
sodium than with metronidazole during 
microsphere formation. Particle diameter is 
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an important factor influencing drug release 
and retention in target tissue.  
 
The size of periodontal pockets varies 
between 1 to 4 mm depending on the disease 
condition [4]. Particle sizes between 20 to 
120 m have been suggested to be suitable 
for periodontal applications [15]. Thus the 
sizes of the microspheres were within the 
desired range. 
 
Previous FT-IR studies conducted in our 
laboratory indicate that there was no 
interaction between gelatin and 
metronidazole [12] or diclofenac sodium 
[10,14].  The smaller peaks in the DSC of the 
physical mixture of unloaded microspheres 
and metronidazole/diclofenac sodium 
compare with those of the individual drugs is 
due to low quantities of the drugs in the 
physical mixture. The completely absence of 
crystalline drug peaks in the microsphere 
formulation, like in the FT-IR spectra, 
indicates the transformation of the drugs from 
crystalline to amorphous state.  
 
It is difficult to mimic the physiological 
environment in periodontal pockets. The drug 
release study was performed in both static 
and dynamic environments. Drug release 
from gelatin microspheres based on the static 
model was designed to mimic the static state 
inside the carbomer gel. The egg membrane 
pouch was used as a model for periodontal 
pocket in order to determine the diffusion of 
drug across biological membrane. Both the 
microspheres and gel formulations sustained 
the drug release more than 4 h, indicating the 
capacity of the formulated gel and 
microspheres to release the drugs for a 
prolonged period. The burst drug release 
produced by both the microspheres and the 
gel formulation would be beneficial in getting 
achieving rapid onset of action. Burst release 
was approx. 10 % higher for gel than for 
microspheres. Thus, the burst and sustained 
release pattern of the gel formulation will be 
useful in treating inflammation and infection 
locally in periodontal cavities. Formulation of 
diclofenac sodium showed faster release 
than the metronidazole. Diclofenac sodium 
formulation showed faster release than 
metronidazole formulation due probably to 
the higher solubility and lower degree of 
cross-linking of the former at pH 7.2. 
 
Higher regression coefficient was obtained 
with Higuchi than with first order and zero 
order. These findings indicate that drug 
release from the microspheres was diffusion-
controlled. With time, drug release rate fell as 
the drug molecule had to diffuse through the 
longer pathway in cross-linked gelatin matrix. 
The n value obtained from the release data of 
microspheres suggests that drug mechanism 




The formulated microspheres showed good 
drug-loading. The gel formulation, which 
consisted of drug-loaded gelatin 
microspheres, showed sustained release of 
diclofenac sodium and metronidazole 
hydrochloride for ≥ 4 h, thus indicating their 
suitability for the sustained delivery of the 
drugs for the treatment of inflammation and 
infections in periodontal pockets. However, 
further studies, including clinical tests are 
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